BioInformant

Your Global Leader in Stem Cell Market Research

Home » conference » Page 8

BioInformant to Sponsor 2015 World Stem Cell Summit to Support Stem Cell Advancement

By Leave a Comment

PRESS RELEASE; Washington, DC; November 17, 1015 — BioInformant, the only market research firm to serve the stem cell sector since it emerged, announces its sponsorship of the upcoming World Stem Cell Summit 2015 produced by the Genetics Policy Institute (GPI). The conference will be held in Atlanta, Georgia, over December 10-12, 2015.

The event is the world’s largest interdisciplinary meeting to bring together stakeholders from across the stem cell and regenerative medicine spectrum. Described as GPI as bringing together “prominent industry leaders, scientists, clinicians, venture capitalists and angel investors, philanthropists, policymakers, and advocates,” the event will provide seven different course tracks featuring more than 200 speakers. [Read more…]

Day 2 Recap for the “Biorepositories and Sample Management Summit”

By Leave a Comment

Biobanks are diverse processing and storage facilities that maintain biospecimens. These stored biological materials can be used for drug development and discovery efforts, precision medicine studies, biomarker-based preclinical research, and more. Increasingly, biobanks are also storing stem cell lines, such as induced pluripotent stem cell lines that are being derived from both healthy and diseased donors. Biobanks can also contain cord blood units collected from newborns, as well as associated tissues that may contain stem cell and progenitor cells, such as umbilical cord blood tissue or placental tissue. [Read more…]

Day 1 Recap for the “Biorepositories and Sample Management Summit”

By Leave a Comment

Biobanks are biomedical research facilities that process and stores a wide variety of biospecimens, to include whole tissue, blood, DNA, plasma, purified saliva, cell lines, stem cell populations, and more. The goal of biobanking is to preserve biological samples for storage, and importantly, potential use at a later point in time. Biobanks are now playing a major role in assisting pharmaceutical companies with drug discovery and development efforts. They are also driving forward precision medicine efforts, as they have the capacity to allow physicians to select the best treatment option for specific patients. However, effectively preserving tens of thousands, or even hundreds of thousands, of biological samples can be a daunting task.

To honor this growing industry, speakers at the “Biorepositories and Sample Management Summit” held today at the Hilton Hotel in Boston, Massachusetts delivered a jam-packed day of content.

We heard presenters discuss biobanking topics that included: [Read more…]

An Introduction to Tissue Print Technologies with Dr. Sandra Gaston

By Leave a Comment

Question and Answer with Dr. Sandra Gaston of Tufts Medical Center

Dr. Sandra Gaston

As a featured speaker for the Biorepositories and Sample Management Summit on October 12-14th, 2015,  in Boston, Massachusetts, Dr. Sandra Gaston will be presenting on “Tissue Print Technologies: An Innovative and Practice Approach to Obtaining High Quality Research Samples from Biopsies and Other Challenging Biospecimens.”

As an attendee and sponsor of the event, I was deeply honored to have the chance to interview Dr. Gaston about her research techniques, novel approaches to specimen management, and the use of these techniques in precision medicine.  Her answers to our interview questions are below. [Read more…]

Cord Blood World Europe – Bringing together Public and Private Banks, Clinicians & Researchers

By 2 Comments

BioInformant is excited and proud to announce our sponsorship of the Cord Blood World Europe Congress 2015 as an essential global event for those participating within the cord blood and regenerative medicine community. BioInformant is deeply committed to advancing progress with human umbilical cord blood, because cord blood contains valuable hematopoietic stem cells and cord tissue (“Wharton’s Jelly”) contains valuable mesenchymal stem cells. 

As the first and only company dedicated to tracking the stem cell market, BioInformant tracks this important market segment within our global strategic report the “Complete 2015-16 Global Cord Blood Industry Report.” We also have an entire section of our blog dedicated to breaking cord blood industry news. Additionally, we have a partnership with the Save the Cord Foundation, a non-profit dedicated to cord blood banking awareness and education, in which we run a joint awareness campaign called “Cord Blood Banking Awareness: Educating America and the World.” The campaign is a global effort to educate currently expecting parents, as well as future parents, grandparents, siblings, and friends, about the medical benefits of cord blood preservation. [Read more…]

BioInformant's World-Class Clients